Study finds DTC ads may help persuade people to quit a medication

06/5/2014 | GeriPal blog

Dr. Eric Widera writes in GeriPal about a clinical trial in Quebec that suggests that direct-to-consumer ads could be used to persuade people to stop using a drug instead of the usual pitch to get them to try it. Researchers, writing in JAMA Internal Medicine, found that more long-term benzodiazepine users ages 65-95 completely stopped using the medication after getting a booklet about the risks of the drug, compared with a control group that did not get the intervention.

View Full Article in:

GeriPal blog

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC